Eflornithine for treatment of high-risk neuroblastoma is a research paper published in Trends in Pharmacological Sciences (2024). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institute of Neurological Disorders and Stroke
Grant: R01NS100947
National Institute of Neurological Disorders and Stroke
Grant: R61NS130199
National Institutes of Health
FWCI
2.23
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals